BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15761925)

  • 1. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities.
    Glomme A; März J; Dressman JB
    J Pharm Sci; 2005 Jan; 94(1):1-16. PubMed ID: 15761925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of sparingly-soluble ionizable drugs.
    Avdeef A
    Adv Drug Deliv Rev; 2007 Jul; 59(7):568-90. PubMed ID: 17644216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods.
    Avdeef A; Berger CM; Brownell C
    Pharm Res; 2000 Jan; 17(1):85-9. PubMed ID: 10714613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery.
    Zhou L; Yang L; Tilton S; Wang J
    J Pharm Sci; 2007 Nov; 96(11):3052-71. PubMed ID: 17722003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility-pH profiles of some acidic, basic and amphoteric drugs.
    Shoghi E; Fuguet E; Bosch E; Ràfols C
    Eur J Pharm Sci; 2013 Jan; 48(1-2):291-300. PubMed ID: 23178441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (log P
    Port A; Bordas M; Enrech R; Pascual R; Rosés M; Ràfols C; Subirats X; Bosch E
    Eur J Pharm Sci; 2018 Sep; 122():331-340. PubMed ID: 30006180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilicity of amphoteric and zwitterionic compounds: A comparative study of determination methods.
    Ràfols C; Subirats X; Rubio J; Rosés M; Bosch E
    Talanta; 2017 Jan; 162():293-299. PubMed ID: 27837832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds.
    Seadeek C; Ando H; Bhattachar SN; Heimbach T; Sonnenberg JL; Blackburn AC
    J Pharm Biomed Anal; 2007 Apr; 43(5):1660-6. PubMed ID: 17270379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification.
    Lin B; Pease JH
    J Pharm Biomed Anal; 2016 Apr; 122():126-40. PubMed ID: 26855285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
    Bharate SS; Vishwakarma RA
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1561-7. PubMed ID: 25740159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly automated assay for determining the aqueous equilibrium solubility of drug discovery compounds.
    Wenlock MC; Austin RP; Potter T; Barton P
    J Lab Autom; 2011 Aug; 16(4):276-84. PubMed ID: 21764023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical aspects of partition measurements according to GLP rules].
    Takácsné Novák K
    Acta Pharm Hung; 1997 Sep; 67(5):179-91. PubMed ID: 9432865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profiling.
    Lucero-Borja D; Subirats X; Barbas R; Prohens R; Avdeef A; Ràfols C
    Eur J Pharm Sci; 2020 May; 148():105305. PubMed ID: 32184154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory study of log P determination by shake-flask and potentiometric methods.
    Takács-Novák K; Avdeef A
    J Pharm Biomed Anal; 1996 Aug; 14(11):1405-13. PubMed ID: 8877846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miniature device for aqueous and non-aqueous solubility measurements during drug discovery.
    Chen XQ; Venkatesh S
    Pharm Res; 2004 Oct; 21(10):1758-61. PubMed ID: 15553219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility measurement of polymorphic compounds via the pH-metric titration technique.
    Fioritto AF; Bhattachar SN; Wesley JA
    Int J Pharm; 2007 Feb; 330(1-2):105-13. PubMed ID: 17049191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid.
    Heikkilä T; Karjalainen M; Ojala K; Partola K; Lammert F; Augustijns P; Urtti A; Yliperttula M; Peltonen L; Hirvonen J
    Int J Pharm; 2011 Feb; 405(1-2):132-6. PubMed ID: 21146596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling, solubility and pK(a) of five sparingly soluble drugs.
    Domańska U; Pobudkowska A; Pelczarska A; Zukowski L
    Int J Pharm; 2011 Jan; 403(1-2):115-22. PubMed ID: 21034801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution--a validation study.
    Box KJ; Völgyi G; Baka E; Stuart M; Takács-Novák K; Comer JE
    J Pharm Sci; 2006 Jun; 95(6):1298-307. PubMed ID: 16552741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-metric solubility. 3. Dissolution titration template method for solubility determination.
    Avdeef A; Berger CM
    Eur J Pharm Sci; 2001 Dec; 14(4):281-91. PubMed ID: 11684402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.